GO:0006898 receptor-mediated endocytosis: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006898 receptor-mediated endocytosis is a biological process in which cell surface receptors bind specific extracellular ligands and deliver them into the cell via clathrin-coated pits and vesicles.
• The process provides selectivity by concentrating specific receptor-ligand complexes while excluding most other plasma-membrane proteins.
• Receptor-mediated endocytosis is essential for nutrient uptake, clearance of signaling molecules, and regulation of cell-surface receptor signaling.
• Defects in this pathway contribute to kidney disease, placental transport disorders, cancer progression, and neurological conditions [1,6,4].
• Key molecular players include clathrin, dynamin, adaptor proteins such as AP-2, and receptors like megalin, transferrin receptor, and LDL receptor [2,6].
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of receptor-mediated endocytosis genes in human cells [1,4].
Description
Receptor-mediated endocytosis (GO:0006898) is a specialized endocytic process that ensures the selective internalization of extracellular macromolecules through specific cell-surface receptors. Unlike bulk fluid-phase uptake, this pathway concentrates receptor-ligand complexes into clathrin-coated pits that pinch off to form transport vesicles, thereby excluding most other plasma-membrane proteins and providing high specificity. This mechanism is fundamental to nutrient acquisition, signal transduction, and clearance of hormones and immune complexes. The pathway is conserved across cell types and is particularly active in polarized cells such as kidney proximal tubule cells and placental syncytiotrophoblasts [1,6]. Researchers study receptor-mediated endocytosis to understand how cells communicate with their environment, how pathogens and nanoparticles enter cells, and how dysregulation contributes to human disease [4,5]. The process also intersects with cytoskeletal dynamics, as actin and microtubule networks facilitate vesicle formation and trafficking. Because of its broad physiological importance, receptor-mediated endocytosis is a frequent target for therapeutic intervention and a focus of CRISPR-based functional genomics [1,4].
receptor-mediated endocytosis At A Glance
| GO ID | GO:0006898 |
|---|---|
| GO term | receptor-mediated endocytosis |
| Ontology | biological_process |
| Synonym | receptor mediated endocytosis |
| Major function | Selective internalization of extracellular ligands via specific cell-surface receptors, typically through clathrin-coated pits and vesicles |
| Cellular location | Plasma membrane, clathrin-coated pits, endocytic vesicles, endosomes |
| Key molecular players | Clathrin, dynamin, AP-2 adaptor complex, specific receptors (e.g., LDLR, TFRC, LRP2/megalin) |
| Associated processes | Nutrient uptake, receptor downregulation, signal transduction, clearance of hormones and immune complexes |
| Research relevance | Target for drug delivery, understanding of disease mechanisms, and CRISPR functional genomics |
What Is GO:0006898?
According to the Gene Ontology, receptor-mediated endocytosis (GO:0006898) is an endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
Why Is receptor-mediated endocytosis Important in Cell Biology?
Receptor-mediated endocytosis is a central mechanism by which cells sample and respond to their environment, and its dysfunction is linked to a wide range of human pathologies [1,2]. It controls the uptake of essential nutrients such as iron and cholesterol, regulates the duration and intensity of cell-surface receptor signaling, and mediates the clearance of circulating ligands. In kidney cells, receptor-mediated endocytosis is critical for reabsorption of filtered proteins, and its impairment leads to proteinuria and progressive renal injury. In the placenta, megalin-mediated endocytosis is essential for maternal-fetal transport of nutrients and vitamins. The pathway is also exploited by pathogens and nanoparticles for cellular entry, making it a key consideration in drug delivery and infectious disease research. Furthermore, receptor-mediated endocytosis modulates signaling pathways by internalizing activated receptors, thereby influencing cell proliferation, differentiation, and survival. Understanding this process at the molecular level is therefore essential for both basic cell biology and translational medicine.
• Controls selective uptake of essential nutrients including cholesterol (via LDLR) and iron (via TFRC).
• Regulates cell-surface receptor signaling by internalizing activated receptors and targeting them for degradation or recycling.
• Mediates clearance of circulating hormones, immune complexes, and other macromolecules.
• Essential for kidney proximal tubule reabsorption; defects cause proteinuria and kidney disease.
• Critical for placental transport of nutrients and vitamins; megalin dysfunction affects fetal development.
• Involved in cancer progression through altered uptake of growth factors and exosomes.
• Exploited by pathogens and nanoparticles for cellular entry, impacting infectious disease and drug delivery.
• Requires cytoskeletal coordination, linking endocytosis to cell motility and polarity.
• Regulated by platelet activation and gelsolin, affecting hemostasis and thrombosis.
• Provides a model system for studying membrane trafficking and organelle biogenesis.
What Happens During receptor-mediated endocytosis?
Ligand binding and receptor clustering
In simple terms: Specific molecules outside the cell bind to matching receptors on the cell surface, and these receptor-ligand pairs gather together.
The process begins when an extracellular ligand binds with high affinity to its specific cell-surface receptor. This binding triggers the clustering of receptor-ligand complexes in the plasma membrane, often within clathrin-coated pits. The specificity of this interaction ensures that only the recognized macromolecule is concentrated for internalization, while other plasma membrane proteins are largely excluded. Examples include the binding of low-density lipoprotein (LDL) to the LDL receptor and transferrin to the transferrin receptor. This step is a key determinant of selectivity in receptor-mediated endocytosis.
Clathrin-coated pit formation and vesicle scission
In simple terms: The cell membrane dimples inward, coated by a protein called clathrin, and then pinches off to form a small bubble carrying the receptor and its cargo.
Following receptor clustering, the cytoplasmic adaptor protein AP-2 recruits clathrin to the membrane, leading to the assembly of a clathrin-coated pit. The GTPase dynamin mediates the scission of the invaginated pit from the plasma membrane, releasing a clathrin-coated vesicle. This vesicle contains the receptor-ligand complexes and excludes most other plasma-membrane proteins, as defined for GO:0006898. The cytoskeleton, particularly actin filaments, contributes to the mechanical forces required for membrane invagination and vesicle formation. The entire process is highly regulated and occurs within minutes of ligand binding.
Uncoating and endosomal delivery
In simple terms: The clathrin coat is removed, and the vesicle delivers its contents to a sorting station inside the cell called an endosome.
After scission, the clathrin coat is rapidly removed by uncoating proteins such as auxilin and Hsc70, allowing the vesicle to fuse with early endosomes. Within the endosome, the acidic environment often causes the receptor to release its ligand. The receptor can then be recycled back to the plasma membrane, while the ligand is sorted for degradation in lysosomes or further processing. This sorting step is critical for maintaining cellular homeostasis and for regulating the availability of receptors at the cell surface. The endosomal system also serves as a signaling platform, as internalized receptors can continue to signal from endosomes.
Receptor recycling and downregulation
In simple terms: Receptors can either go back to the cell surface to be used again or be destroyed, which controls how sensitive the cell is to signals.
Following internalization, receptors are sorted in endosomes either for recycling to the plasma membrane or for degradation in lysosomes. Recycling allows the cell to reuse receptors for multiple rounds of ligand uptake, whereas degradation leads to downregulation of the receptor and a decrease in cellular responsiveness to the ligand. The balance between recycling and degradation is regulated by ubiquitination, sorting nexins, and the endosomal sorting complex required for transport (ESCRT) machinery. This regulation is essential for processes such as nutrient uptake, cell signaling, and immune responses. Dysregulation of receptor sorting contributes to diseases including cancer and neurodegeneration.
Key Genes Involved in GO:0006898 receptor-mediated endocytosis
The following genes and proteins are central to receptor-mediated endocytosis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLTC | Clathrin heavy chain; major structural component of coated pits and vesicles | Knockout studies reveal defects in endocytosis and receptor recycling |
| CLTA | Clathrin light chain; regulates clathrin assembly and disassembly | Modulates endocytic efficiency and cargo selection |
| AP2M1 | AP-2 adaptor complex subunit; recruits clathrin and cargo receptors | Essential for clathrin-coated pit formation; knockout impairs endocytosis |
| DNM2 | Dynamin 2; GTPase mediating vesicle scission | Mutations cause centronuclear myopathy; knockout blocks endocytosis |
| LRP2 | Megalin; multiligand receptor in kidney and placenta | Knockout leads to proteinuria and developmental defects |
| LDLR | Low-density lipoprotein receptor; mediates cholesterol uptake | Mutations cause familial hypercholesterolemia |
| TFRC | Transferrin receptor; mediates iron uptake | Knockout is lethal; regulates iron homeostasis |
| EGFR | Epidermal growth factor receptor; internalized upon ligand binding | Endocytosis regulates signaling duration and cancer progression |
| GSN | Gelsolin; actin-severing protein involved in endocytosis | Regulates receptor-mediated and fluid-phase endocytosis in platelets |
| RAB5A | Early endosome marker; regulates endosome fusion | Knockdown impairs endosomal sorting and receptor recycling |
| RAB7A | Late endosome/lysosome trafficking | Knockout affects receptor degradation and lysosomal delivery |
| SNX1 | Sorting nexin 1; endosomal sorting and recycling | Regulates receptor recycling and signaling |
| EPS15 | EGFR pathway substrate 15; clathrin adaptor | Required for efficient endocytosis of EGFR and other receptors |
| ITSN1 | Intersectin 1; scaffold protein in clathrin-mediated endocytosis | Knockdown inhibits endocytosis and synaptic vesicle recycling |
| PICALM | Phosphatidylinositol binding clathrin assembly protein | GWAS risk factor for Alzheimer's disease; regulates endocytosis |
| BIN1 | Bridging integrator 1; membrane curvature and endocytosis | Risk factor for Alzheimer's disease; regulates endocytic trafficking |
| VPS35 | Retromer component; endosomal recycling | Mutations cause Parkinson's disease; affects receptor recycling |
How Is receptor-mediated endocytosis Regulated?
Receptor-mediated endocytosis is regulated at multiple levels, including receptor availability, post-translational modifications, and signaling feedback. Phosphorylation of receptors and adaptor proteins can modulate the efficiency of internalization. Ubiquitination of receptors serves as a signal for sorting into the endosomal pathway and can determine whether they are recycled or degraded. The actin cytoskeleton and its regulators, such as gelsolin, dynamically control membrane invagination and vesicle scission [3,5]. In platelets, gelsolin deficiency impairs both receptor-mediated and fluid-phase endocytosis, highlighting its regulatory role. Additionally, the endocytic machinery is subject to regulation by small GTPases of the Rab family, which control vesicle trafficking and fusion. Signaling from internalized receptors can also feedback to regulate the endocytic process itself.
receptor-mediated endocytosis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LRP2 | Donnai-Barrow syndrome; proteinuria | Knockout kidney organoids or mouse models |
| LDLR | Familial hypercholesterolemia | Knockout HepG2 cells; knock-in patient mutations |
| GSN | Platelet dysfunction; bleeding disorders | Knockout platelets or megakaryocytes |
| PICALM | Alzheimer's disease | Knockout neurons; overexpression in cell lines |
| VPS35 | Parkinson's disease | Knock-in mutant mice; patient iPSC-derived neurons |
Kidney disease and proteinuria
Receptor-mediated endocytosis in kidney proximal tubule cells is essential for reabsorbing filtered proteins, including albumin and low-molecular-weight proteins. Megalin (LRP2) and cubilin are key receptors mediating this uptake. Defects in this pathway lead to proteinuria, which is a hallmark of chronic kidney disease and can progress to renal failure. Studies in animal models and human patients have shown that mutations in LRP2 cause Donnai-Barrow syndrome, characterized by proteinuria and developmental abnormalities. Understanding the molecular mechanisms of receptor-mediated endocytosis in the kidney is therefore critical for developing therapies for proteinuric kidney diseases.
Placental transport and fetal development
The human placenta expresses high levels of megalin, which mediates the uptake of essential nutrients, vitamins, and carrier proteins from maternal circulation. Receptor-mediated endocytosis across the placenta is crucial for fetal growth and development. Dysregulation of this process has been linked to intrauterine growth restriction and other pregnancy complications. Research on placental receptor-mediated endocytosis informs drug delivery strategies and understanding of maternal-fetal transport.
Cancer and exosome uptake
Cancer cells often exhibit altered receptor-mediated endocytosis to support their high metabolic demands and to internalize growth factors and exosomes. Exosomes, small extracellular vesicles, can be taken up by recipient cells through receptor-mediated endocytosis, thereby transferring oncogenic signals and promoting tumor progression. Targeting endocytic pathways is being explored as a therapeutic strategy to inhibit cancer cell proliferation and metastasis. Additionally, receptor-mediated endocytosis influences the response to targeted therapies by regulating the availability of cell-surface receptors.
Neurological disorders
Neurons rely heavily on receptor-mediated endocytosis for synaptic vesicle recycling, nutrient uptake, and clearance of aggregated proteins. Defects in endocytic genes such as PICALM and BIN1 have been associated with Alzheimer's disease through genome-wide association studies. Impaired endocytosis can lead to accumulation of toxic proteins and synaptic dysfunction. Understanding how receptor-mediated endocytosis contributes to neurodegeneration may reveal new therapeutic targets.
From receptor-mediated endocytosis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CLTC impair receptor-mediated endocytosis? | CLTC knockout HeLa or HEK293 cells |
| How does a disease-associated point mutation in LRP2 affect ligand uptake? | LRP2 point-mutation knock-in kidney cells |
| Can we visualize receptor recycling in real time? | TFRC tagged with GFP knock-in cells |
| Does overexpression of DNM2 enhance endocytic rate? | DNM2 overexpression in fibroblasts |
| Which genes are essential for endocytosis in a genome-wide screen? | CRISPR knockout library screening in K562 cells |
| How does gelsolin regulate endocytosis in platelets? | GSN knockout megakaryocytes differentiated from iPSCs |
How to Study the receptor-mediated endocytosis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Localization and dynamics of receptors and vesicles | Live-cell imaging of clathrin-coated pits |
| Flow cytometry | Internalization of fluorescent ligands | Quantifying transferrin uptake in mutant cells |
| Radioligand uptake assay | Rate and extent of ligand internalization | Comparing wild-type and knockout cells |
| Proximity labeling (BioID) | Protein-protein interactions in endocytic vesicles | Identifying novel endocytic regulators |
| CRISPR knockout screen | Genes essential for endocytosis | Genome-wide discovery of endocytic factors |
| RNA-seq | Transcriptional changes upon endocytic perturbation | Evaluating feedback regulation |
| Western blot | Receptor degradation or recycling | Measuring EGFR downregulation |
Fluorescence microscopy and live-cell imaging
Fluorescence microscopy using fluorescently labeled ligands (e.g., transferrin, LDL) or tagged receptors (e.g., GFP-TFRC) allows visualization of receptor-mediated endocytosis in real time. Total internal reflection fluorescence (TIRF) microscopy can capture clathrin-coated pit formation and vesicle scission at the plasma membrane. These methods provide spatial and temporal resolution of endocytic events.
Biochemical uptake assays
Radiolabeled or fluorescent ligands are used to quantify internalization rates in cell populations. After incubation at 37°C, surface-bound ligand is removed by acid wash, and internalized ligand is measured by scintillation counting or flow cytometry. These assays are robust for comparing wild-type and mutant cells.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with clathrin-coated vesicles or endosomes. Proximity labeling (e.g., BioID) and co-immunoprecipitation coupled to mass spectrometry reveal the endocytic interactome. These approaches uncover novel regulators and disease-related mutations.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes required for receptor-mediated endocytosis. Cells are incubated with a cytotoxic ligand (e.g., diphtheria toxin) that enters via endocytosis, and resistant colonies are sequenced to identify enriched sgRNAs. This unbiased approach has revealed new endocytic factors and potential drug targets.
How CRISPR Can Be Used to Study GO:0006898 receptor-mediated endocytosis
Knockout
CRISPR knockout of genes such as CLTC, AP2M1, or DNM2 completely abolishes receptor-mediated endocytosis, providing definitive evidence of their requirement. Knockout cell lines are valuable for studying the consequences of endocytic defects on signaling and metabolism. EDITGENE offers custom knockout cell models in various cell types, including kidney and neuronal cells.
Point Mutation
Point mutations identified in patients (e.g., in LRP2 or LDLR) can be introduced into cell lines using CRISPR base editing or homology-directed repair to study their functional impact [1,6]. These models help distinguish pathogenic mutations from benign polymorphisms and reveal molecular mechanisms.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci such as TFRC or CLTC allows real-time visualization of receptor trafficking and vesicle dynamics. Tagged knock-in models preserve endogenous regulation and are ideal for live-cell imaging.
Overexpression
Overexpression of endocytic proteins such as dynamin or gelsolin can enhance or perturb endocytic rates, enabling gain-of-function studies. CRISPR activation (CRISPRa) can achieve tunable overexpression without the need for exogenous constructs. EDITGENE provides overexpression cell models for studying endocytic regulation.
How EDITGENE Supports receptor-mediated endocytosis Research
Researchers studying receptor-mediated endocytosis-related genes often need to determine whether a candidate gene is causally involved in ligand uptake, receptor recycling, or disease-associated phenotypes. EDITGENE provides a comprehensive suite of CRISPR-based cell model services to accelerate this research, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for receptor-mediated endocytosis research.
Frequently Asked Questions About receptor-mediated endocytosis
What is receptor-mediated endocytosis?
Receptor-mediated endocytosis (GO:0006898) is a biological process in which cell surface receptors bind specific extracellular ligands and internalize them via clathrin-coated pits and vesicles, ensuring selective transport.
What genes are involved in receptor-mediated endocytosis?
Key genes include CLTC, AP2M1, DNM2, LRP2, LDLR, TFRC, EGFR, GSN, RAB5A, and PICALM, among others [2,6,5].
What is the function of GO:0006898?
The function is to selectively internalize extracellular macromolecules through specific receptors, typically via clathrin-coated pits, thereby regulating nutrient uptake and cell signaling.
How does receptor-mediated endocytosis differ from phagocytosis?
Receptor-mediated endocytosis is a highly selective process for specific ligands via clathrin-coated pits, whereas phagocytosis is the engulfment of large particles and is not primarily receptor-specific.
What diseases are associated with defective receptor-mediated endocytosis?
Defects are linked to kidney disease (proteinuria), familial hypercholesterolemia, Alzheimer's disease, Parkinson's disease, and placental transport disorders [1,6,2].
What is the role of clathrin in receptor-mediated endocytosis?
Clathrin is the major structural protein that forms the coat of endocytic vesicles, concentrating receptor-ligand complexes and driving membrane invagination.
How can I study receptor-mediated endocytosis in the lab?
Common methods include fluorescence microscopy with labeled ligands, radioligand uptake assays, proteomics, and CRISPR screens [2,4].
What is the role of dynamin in endocytosis?
Dynamin is a GTPase that mediates the scission of clathrin-coated pits from the plasma membrane, releasing the vesicle.
Can receptor-mediated endocytosis be targeted for drug delivery?
Yes, ligands or nanoparticles can be designed to bind specific receptors and exploit this pathway for targeted drug delivery.
What CRISPR models are available for studying receptor-mediated endocytosis?
EDITGENE offers knockout, point mutation, knock-in, overexpression cell models, and CRISPR library screening for endocytosis genes [1,4].
Conclusion
Receptor-mediated endocytosis (GO:0006898) is a fundamental cellular process that ensures the selective uptake of extracellular molecules and regulates signaling. Its importance spans nutrient acquisition, kidney function, placental transport, and neurological health [1,2,6]. Dysregulation of this pathway contributes to a variety of human diseases, making it a key area of biomedical research [1,4,7]. Advances in CRISPR-based genome editing and functional genomics now allow researchers to dissect the molecular mechanisms of receptor-mediated endocytosis with unprecedented precision [1,4]. EDITGENE provides the tools and services needed to accelerate these discoveries, from custom knockout cell lines to genome-wide screens.
References
- 1. Rodrigues MC et al.. 2024. Receptor-mediated endocytosis in kidney cells during physiological and pathological conditions.. Curr Top Membr 93:1-25 PMID: 39181576
- 2. Wileman T et al.. 1985. Receptor-mediated endocytosis.. Biochem J 232(1):1-14 PMID: 2867759
- 3. Kornilova ES. 2014. Receptor-mediated endocytosis and cytoskeleton.. Biochemistry (Mosc) 79(9):865-78 PMID: 25385015
- 4. Gonda A et al.. 2019. Internalization of Exosomes through Receptor-Mediated Endocytosis.. Mol Cancer Res 17(2):337-347 PMID: 30487244
- 5. Paul M et al.. 2024. Gelsolin regulates receptor-mediated and fluid-phase endocytosis in platelets.. J Thromb Haemost 22(9):2601-2607 PMID: 38777258
- 6. Akour AA et al.. 2013. Receptor-mediated endocytosis across human placenta: emphasis on megalin.. Mol Pharm 10(4):1269-78 PMID: 23438198
- 7. Irannejad R et al.. 2015. Effects of endocytosis on receptor-mediated signaling.. Curr Opin Cell Biol 35:137-43 PMID: 26057614
